The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM

23 Jan 2009 11:23

RNS Number : 1558M
China Growth Opportunities Ltd
23 January 2009
 



23 January 2009

China Growth Opportunities Limited

("China Growth" or "the Company")

Result of EGM 

The Directors of the Company announce the results of the Resolutions put to Shareholders of the Company at the EGM held earlier today:

Resolution

For Resolution

Against Resolution

Result

1

To amend the "Investment Objective" of the Company

24,493,511

19,750,916

Approved

2

To remove Robert Leighton as a Director

23,893,511

20,350,916

Approved

3

To remove Mark Huntley as a Director

23,893,511

20,350,916

Approved

4

To remove Victor Ng as a Director

23,893,511

20,350,916

Approved

5

To appoint Rhys Davies as a Director

23,893,511

20,350,916

Approved

6

To appoint Brett Miller as a Director

23,893,511

20,350,916

Approved

Note: There are currently 50 million Ordinary shares in issue

As a result of the EGM:

(i) the investment objective of the Company has been amended to be: "The investment objective of the Company is to manage the sale of the Company's investment portfolio and to maximise the return of invested capital to Shareholders during the period ending on 30 September 2010"

(ii) Messrs Roy Leighton, Mark Huntley and Victor Ng, are no longer Directors of the Company as of today; and

(iii) Messrs Rhys Davies and Brett Miller have today been appointed Directors of the Company.

As indicated in the Circular, Mr Richard Battey has today resigned from the Board of the Company.

The Board of the Company therefore currently comprises Rhys Davies (Chairman and Non-Executive Director), Brett Miller (Non-Executive Director) and Simon Littlewood (Executive Director).

The Directors will appoint an additional suitable independent Non-Executive Director as soon as practicable. The composition of the Board of the Company is subject to the approval of the Guernsey Financial Services Commission.

 

Enquiries

Hugh Field

Collins Stewart Europe Limited

Tel: +44 20 7523 8000

Jeremy Carey / Andrew Dunn

Tavistock Communications

Tel: +44 20 7920 3150

Rhys Davies, a resident of Switzerland, is a Chartered Financial Analyst and has nearly fifteen years of continuous investment management experience since joining Schroder Investment Management Limited in 1994. Since 1998, Mr Davies has served as managing director of Glendower Capital Limited and Glendower Partners Limited. He is also a non-executive Director of Osprey Smaller Companies Income Fund Limited, The Local Radio Company PLC, an AIM-listed company, and several private companies. Mr Davies holds degrees from the University of Wales and Imperial College of Science, Technology and Medicine.

Rhys Cathan Davies (aged 40) holds or has held the following directorships, and is or was a member of the following partnerships during the past five years:

Current Directorships / Partnerships:

Past Directorships / Partnerships:

Broighter Capital Sarl

Agenda Television Limited

Damille Partners II

Fairholt Resource Investments Limited

Glendower Capital Limited

Heblerb Limited

Glendower Opportunity Partners II

New Fulcrum Investment Trust Plc

Glendower Partners Limited

The Television Corporation Limited

Hallwood Investments Limited

Tinopolis Plc

Interactive Rights Management Limited

Xmarc Limited

Osprey Smaller Companies Income Fund Limited

Sanoodi Limited

SBC Management Sarl

Sports Brands Corporation Sarl

The Local Radio Company Plc

Wightman Cup Limited

Wightman Cup Limited (Gibraltar)

Brett Miller graduated from the University of the Witwatersrand (South Africa) with a Bachelors degree majoring in law and economics and additionally holds a law degree from the London School of Economics (after having relocated to the United Kingdom in 1988). He joined Nabarro Nathanson, a London-based law firm, in September 1993 where he practiced until December 1997. He has specialised in mergers and acquisitions and corporate finance in the energy and natural resources and smaller companies sectors. He is currently Managing Director and key shareholder of Ruegg & Co Limited, a London based corporate finance boutique which is active in bringing new issues to the AIM and PLUS markets.

Brett Lance Miller (aged 41) holds or has held the following directorships, and is or was a member of the following partnerships during the past five years:

Current Directorships / Partnerships:

Past Directorships / Partnerships:

Damille Partners II

17 Gledhow Gardens Management Company Limited

Globo Plc

Gledhow Investments Plc

Pactolus Hungarian Property plc

West China Cement Limited

Mr Davies and Mr Miller, through their holding in Damille Partners II (in which they each hold an equal beneficial partnership interest), are beneficially interested in 5,100,000 Shares in the Company.

There are no further disclosures required in respect of Mr Davies and Mr Miller under paragraph (g) of Schedule Two of the AIM Rules for Companies.

--oo--

The definitions used in this announcement are as set out in the Circular to Shareholders dated 29 December 2008.

Collins Stewart Europe Limited is acting for China Growth Opportunities Limited and no one else in connection with the Proposals and will not be responsible to any person other than China Growth Opportunities Limited for providing the protections afforded to clients of Collins Stewart Europe Limited or for providing advice in relation to the Proposals.

--ENDS--

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGSESFFDSUSEEF
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.